These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 19246930

  • 1. Long-term effects of valproic acid on reproductive endocrine functions in Turkish women with epilepsy.
    Gorkemli H, Genc BO, Dogan EA, Genc E, Ozdemir S.
    Gynecol Obstet Invest; 2009; 67(4):223-7. PubMed ID: 19246930
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study.
    Prabhakar S, Sahota P, Kharbanda PS, Siali R, Jain V, Lal V, Khurana D.
    Epilepsia; 2007 Jul; 48(7):1371-7. PubMed ID: 17441994
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
    Hu X, Wang J, Dong W, Fang Q, Hu L, Liu C.
    Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
    [Abstract] [Full Text] [Related]

  • 6. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
    Isojärvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä VV.
    N Engl J Med; 1993 Nov 04; 329(19):1383-8. PubMed ID: 8413434
    [Abstract] [Full Text] [Related]

  • 7. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G, Abraham I, Haslinger M, Trinka E, Seppi K, Unterberger I, Alge A, Windisch J, Lechleitner M, Bauer G.
    J Neurol; 2002 Jul 04; 249(7):835-41. PubMed ID: 12140666
    [Abstract] [Full Text] [Related]

  • 8. [Epilepsy and disorders of reproduction].
    Dravecká I, Lazúrová I.
    Vnitr Lek; 2007 Jan 04; 53(1):46-53. PubMed ID: 17472015
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report.
    Joffe H, Cohen LS, Suppes T, Hwang CH, Molay F, Adams JM, Sachs GS, Hall JE.
    Biol Psychiatry; 2006 Dec 15; 60(12):1378-81. PubMed ID: 16950230
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Valproate and polycystic ovaries.
    Eberle AJ.
    J Am Acad Child Adolesc Psychiatry; 1998 Oct 15; 37(10):1009. PubMed ID: 9785710
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Endocrine effects of valproate in adolescent girls with epilepsy.
    de Vries L, Karasik A, Landau Z, Phillip M, Kiviti S, Goldberg-Stern H.
    Epilepsia; 2007 Mar 15; 48(3):470-7. PubMed ID: 17326798
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.